SG Trading Solutions LLC Purchases New Shares in Danaher Corporation $DHR

SG Trading Solutions LLC acquired a new stake in Danaher Corporation (NYSE:DHR) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 2,860 shares of the conglomerate’s stock, valued at approximately $655,000.

Several other large investors also recently made changes to their positions in the business. Elevated Capital Advisors LLC bought a new stake in Danaher during the 4th quarter worth about $26,000. Hilton Head Capital Partners LLC acquired a new stake in Danaher in the 4th quarter valued at about $27,000. Clal Insurance Enterprises Holdings Ltd raised its stake in shares of Danaher by 71.6% in the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock worth $29,000 after acquiring an additional 53 shares during the last quarter. JPL Wealth Management LLC acquired a new position in shares of Danaher during the third quarter worth approximately $25,000. Finally, WFA of San Diego LLC acquired a new position in shares of Danaher during the second quarter worth approximately $26,000. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Up 0.3%

Shares of NYSE:DHR opened at $177.74 on Friday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52. The stock has a market cap of $125.80 billion, a price-to-earnings ratio of 34.38, a P/E/G ratio of 2.26 and a beta of 0.81. The company has a 50 day moving average of $179.62 and a 200-day moving average of $203.07. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, beating the consensus estimate of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The business had revenue of $5.95 billion for the quarter, compared to analyst estimates of $6 billion. During the same period in the prior year, the business posted $1.88 earnings per share. Danaher’s revenue was up 3.7% compared to the same quarter last year. On average, sell-side analysts forecast that Danaher Corporation will post 8.45 earnings per share for the current year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be paid a $0.40 dividend. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. Danaher’s dividend payout ratio is 30.95%.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on DHR. Wall Street Zen lowered shares of Danaher from a “buy” rating to a “hold” rating in a report on Saturday, April 25th. Morgan Stanley reduced their price objective on Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a report on Wednesday, April 22nd. Wells Fargo & Company decreased their price objective on Danaher from $240.00 to $212.00 and set an “equal weight” rating on the stock in a research report on Wednesday, April 22nd. Jefferies Financial Group reissued a “buy” rating and issued a $245.00 target price on shares of Danaher in a research note on Tuesday, April 21st. Finally, Barclays dropped their target price on Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a research report on Tuesday, April 14th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $233.61.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.